Gland Pharma Ltd.
GLANDHealthcareR1 raw held document library
Coverage
| Dataset | On disk | Usable | State |
|---|---|---|---|
| Results XBRL (NSE + BSE) | 58 | 22 | 22 quarter-ends |
| Annual reports | 6 | 6 | identity graded |
| Earnings calls | 22 | 22 | transcripts and analyst meets only |
| Shareholding | 20 | 20 | |
| Related party | 4 | 4 | |
| Investor decks | 0 | 0 | cohort of 48 companies only |
Financial statements in parse — expected 19 Sep 2026. Nothing from the superseded legacy store is shown.
Earnings calls
22 transcript(s)/analyst meet(s) served; 0 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 22 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| TRANSCRIPT | 20210210 | 2020-12-31 | yes | |
| TRANSCRIPT | 20210521 | 2021-03-31 | yes | |
| TRANSCRIPT | 20210731 | 2021-06-30 | yes | |
| TRANSCRIPT | 20211103 | 2021-09-30 | yes | |
| TRANSCRIPT | 20220128 | 2021-12-31 | yes | |
| TRANSCRIPT | 20220526 | 2022-03-31 | yes | |
| TRANSCRIPT | 20220727 | 2022-06-30 | yes | |
| TRANSCRIPT | 20221102 | 2022-09-30 | yes | |
| TRANSCRIPT | 20230131 | 2022-12-31 | yes | |
| TRANSCRIPT | 20230525 | 2023-03-31 | yes | |
| TRANSCRIPT | 20230811 | 2023-06-30 | yes | |
| TRANSCRIPT | 20240221 | 2023-12-31 | yes | |
| TRANSCRIPT | 20240529 | 2024-03-31 | yes | |
| TRANSCRIPT | 20240812 | 2024-06-30 | yes | |
| TRANSCRIPT | 20241111 | 2024-09-30 | yes | |
| TRANSCRIPT | 20250210 | 2024-12-31 | yes | |
| TRANSCRIPT | 20250527 | 2025-03-31 | yes | |
| TRANSCRIPT | 20250811 | 2025-06-30 | yes | |
| TRANSCRIPT | 20251107 | 2025-09-30 | yes | |
| TRANSCRIPT | 20260203 | 2025-12-31 | yes | |
| TRANSCRIPT | 20260520 | 2026-03-31 | yes | |
| TRANSCRIPT | 20260817 | 2026-06-30 | yes |